Quantitative Proteomics Based on iTRAQ Reveal that Nitidine Chloride Induces Apoptosis by Activating JNK/c-Jun

Shipeng Chen1,2, Yinan Liao1, Jinyan Lv1

  • 1School of Pharmaceutical Sciences, Guangxi Medical University, Nanning, Guangxi, China.

Planta Medica
|February 1, 2022
PubMed

Insights

Nitidine chloride (NC) inhibits liver cancer cell proliferation and induces apoptosis by damaging mitochondria. This occurs through the activation of the JNK/c-Jun signaling pathway, revealing a novel therapeutic mechanism for hepatocellular carcinoma.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Identifying novel therapeutic agents and understanding their mechanisms of action are crucial for improving HCC treatment outcomes.

Purpose of the Study:

  • To investigate the cytotoxic effects of nitidine chloride (NC) on hepatocellular carcinoma cells.
  • To elucidate the molecular mechanisms underlying NC's action using quantitative proteomics.

Main Methods:

  • MTT assays and flow cytometry for proliferation and apoptosis analysis.
  • iTRAQ-based quantitative proteomics to identify differentially expressed proteins.
  • Bioinformatic analysis, molecular docking, qRT-PCR, and Western blotting to validate targets.

Main Results:

  • NC inhibited Bel-7402 liver cancer cell proliferation and induced apoptosis.
  • Proteomics identified mitochondrial damage and implicated AP-1 (c-Jun) as a potential target.
  • Molecular docking and expression analysis confirmed JNK/c-Jun pathway activation.

Conclusions:

  • Nitidine chloride induces hepatocellular carcinoma cell apoptosis via mitochondrial damage.
  • The JNK/c-Jun signaling pathway is activated by NC, presenting a potential therapeutic strategy for HCC.